Brent Johnston

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Ankylosing Spondylitis

Pseudomonas Aeruginosa

Systemic Lupus Erythematosus

Top Venues

Journal for immunotherapy of cancer

Infection and immunity

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Nelson, Simon Gebremeskel, Brian D Lichty, Brent Johnston
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression. Journal for immunotherapy of cancer 10 (3) (2022)
Simon Gebremeskel, Adam Nelson, Brynn Walker, Tora Oliphant, Lynnea Lobert, Douglas Mahoney, Brent Johnston
Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis. Journal for immunotherapy of cancer 9 (3) (2021)
Adam Nelson, Jordan D Lukacs, Brent Johnston
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead. Cancers 13 (20) (2021)
Toka Omar, Pascal Ziltener, Erin Chamberlain, Zhengyu Cheng, Brent Johnston
Mice Lacking γδ T Cells Exhibit Impaired Clearance of Pseudomonas aeruginosa Lung Infection and Excessive Production of Inflammatory Cytokines. Infection and immunity 88 (6) (2020)
Bassel Dawod, Jinghua Liu, Simon Gebremeskel, Chi Yan, Antonia Sappong, Brent Johnston, David W Hoskin, Jean S Marshall, Jun Wang
Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas. Scientific reports 10 (1) (2020)
Richard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri, Simon Gebremeskel, Brent Johnston, Christian Lehmann, Jürgen Fingerle, Benno Rothenhäusler, Camille Perret, Mark Rogers-Evans, Atsushi Kimbara, Matthias Nettekoven, Wolfgang Guba, Uwe Grether, Christoph Ullmer, Melanie E M Kelly
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis. Molecules (Basel, Switzerland) 24 (18) (2019)